Lv2
180 积分 2023-11-27 加入
Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
12小时前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
20天前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
21天前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
21天前
已完结
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
2个月前
已完结
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
2个月前
已完结
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study
3个月前
已完结
Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis: A multicenter real-world study in China
3个月前
已完结
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study
3个月前
已完结
Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study
3个月前
已完结
皖公网安备34019202002308
